Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery. Its platform delivers macrocycle candidates, termed nCycles. These are optimized for oral bioavailability, which has historically hindered therapeutic development of this versatile class of molecules. The company's pipeline is